Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Phase II trial of ZD1694 (Tomudex) in patients with advanced pancreatic cancer.

Phase II trial of ZD1694 (Tomudex) in patients with advanced pancreatic cancer. Invest New Drugs. 1996; 13(4):355-8.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.